arrow_back Back to App

Digital Drug Information: Easier Access and Choice of Format

This act aims to improve access to drug information by allowing manufacturers to provide it primarily digitally. Patients and healthcare providers will still be able to request paper leaflets free of charge. The changes seek to modernize the system and potentially reduce costs.
Key points
Drug information (leaflets) will be primarily available digitally, potentially allowing quicker access to updated data.
Patients and healthcare professionals retain the right to receive a paper version of the leaflet upon request, at no additional cost.
Regulations are designed to minimize negative economic impacts on prescribers and dispensers while modernizing the system.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_7559
Sponsor: Rep. Sherrill, Mikie [D-NJ-11]
Process start date: 2022-04-21
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Prescription Information Modernization Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_7559.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-04-21.

What are the main provisions?

Key points include:

  • Drug information (leaflets) will be primarily available digitally, potentially allowing quicker access to updated data.
  • Patients and healthcare professionals retain the right to receive a paper version of the leaflet upon request, at no additional cost.
  • Regulations are designed to minimize negative economic impacts on prescribers and dispensers while modernizing the system.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Sherrill, Mikie [D-NJ-11].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health Informatization